期刊文献+

正确认识血小板功能检测在急性冠状动脉综合征患者抗血小板治疗中的价值 被引量:3

Deciphering the platelet function test inacute coronary syndrome patients subjected to anti-platelet therapy
原文传递
导出
摘要 抗血小板治疗是急性冠脉综合征(ACS)治疗的基石,血小板功能检测可以评估抗血小板治疗的效果,而关于血小板功能检测是否能用于指导ACS抗血小板治疗依然存在争论。另外血小板功能检测的方法众多,常见用于抗血小板治疗监测的检测方法各有优缺点。根据近年循证资料、指南共识和临床经验,对ACS疾病中,血小板功能检测的目标人群、药物、检测方法、质量保证及结果解释进行综述,希望能有助于检验人员和临床医生正确理解血小板功能检测在ACS患者抗血小板治疗中的意义。 Anti-platelet therapy plays a key role in acute coronary syndrome (ACS) treatments Platelet function tests could monitor the effect of anti-platelet drugs', however, it is still under debate that whether platelet function monitoring could be used to adjust antiplatelet therapy. Additionally, there are a number of platelet function assays, and each of them has specifically advantages and disadvantages, This article reviewed evidence-based information, guidelines, consensus and clinical experience about platelet function monitoring in ACS patients, which was intend to help laboratory technicians and clinicians understanding the value of platelet function tests in monitoring anti-platelet therapy.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2016年第10期743-746,共4页 Chinese Journal of Laboratory Medicine
关键词 急性冠脉综合征 血小板功能试验 血小板聚集抑制剂 Acute coronary syndrome Platelet function test Platelet aggregation inhibitor
  • 相关文献

参考文献31

  • 1Tantry US, Bonello L, Aradi D, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding [ J ]. J Am Coil Cardiol, 2013,62 (24) : 2261-2273. 被引量:1
  • 2Aradi D, Storey RF, Kom6csi A, et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention [ J ]. Eur Heart J, 2014,35 (4) :209-215. 被引量:1
  • 3Schr K, Weber AA, Hohlfeld T. Clopidogrel "resistance" and statin cotreatment - significant for cardiocoronary prevention in real life? [J]. Thromb Haemost, 2005,94(2):235-237. 被引量:1
  • 4Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/ AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [ J ]. J Am Coil Cardiol, 2011,58 (24) : e44-122. 被引量:1
  • 5Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction ( updating the 2007 guideline and replacing the 2011 focused update) : a report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines [ J ]. J Am Coil Cardiol, 2012,60 (7) :645.-681. 被引量:1
  • 62014抗血小板药物治疗反应多样性临床检测和处理的中国专家建议[J].临床荟萃,2015,30(4):366-366. 被引量:17
  • 7Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) [J]. Ear Heart J, 2014,35 (37) :2541-2619. 被引量:1
  • 8Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis[ J]. BMJ, 2008,336(7637) :195-198. 被引量:1
  • 9Mehta SR, Bassand JP, Chrolavicius S, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes [ J ]. N Engl J Med, 2010, 363 ( 10 ) : 930-942. 被引量:1
  • 10Gurm HS, Eagle KA. Defining the optimal dose of aspirin and clopidogrel in acute coronary syndromes [ J ]. Expert Opin Pharmacother,2011,12 ( 1 ) : 149-151. 被引量:1

二级参考文献28

  • 1王海,邸平,齐晓伟.血栓弹力图实验操作影响因素的探讨[J].血栓与止血学,2011,17(6):272-274. 被引量:10
  • 2陆再英;钟南山.内科学[M]北京:人民卫生出版社,2008267-302. 被引量:1
  • 3Nguyen TA,Diodati JG,Pharand C. Resistance to clopidogrel:A review of the evidence[J].Journal of the American College of Cardiology,2005,(08):1157-1164.doi:10.1016/j.jacc.2005.01.034. 被引量:1
  • 4Mehta SR,Bassand JP,Chrolavicius S. Design and rationale of CURRENT-OASIS 7:A randomized,2 ×2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy[J].American Heart Journal,2008,(06):1080-1088.doi:10.1016/j.ahj.2008.07.026. 被引量:1
  • 5Price MJ,Berger PB,Teirstein PS. Standard-vs-high-dose clopidegrel based on platelet function testing after percutaneous coronaty intervention[J].Journal of the American Medical Association,2011,(11):1097-1105.doi:10.1001/jama.2011.290. 被引量:1
  • 6Bhatt DL,Cryer BL,Contant CF. Clopidogrel with or without omeprazole in coronary rateasy disease[J].New England Journal of Medicine,2010,(20):1909-1917.doi:10.1056/NEJMoa1007964. 被引量:1
  • 7Gilard M,Arnaud B,Cornily JC. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin:the randomized,double-blind OCLA study[J].Journal of the American College of Cardiology,2008,(03):256-260.doi:10.1016/j.jacc.2007.06.064. 被引量:1
  • 8Wu Y, Ahmad SS, Zhou J, et al mediates platelet aggregation, Blood,2012,119:1737-1746. 被引量:1
  • 9The disulfide isomerase Erp57 hemostasis, and thrombosis. Cattaneo M. Resistance to anti-platelet agents. Thromb Res, 2011,127 : $61-63. 被引量:1
  • 10Grosser T, Fries S, Lawson JA, et al. Drug resistance and pseu- doresistance:an unintend onequence of enteric coating aspirin. Circulation, 2013,127 : 377-385. 被引量:1

共引文献20

同被引文献21

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部